Kawin Technology(SH:688687) Xin Lang Cai Jing·2025-10-14 02:05Core Insights - Kain Technology's stock increased by 5.19% to 29.20 CNY per share, with a total market capitalization of 4.992 billion CNY as of October 14 [1] Company Overview - Kain Technology, established on August 20, 2008, is located in Beijing Economic and Technological Development Zone and was listed on February 8, 2021 [1] - The company focuses on the research, production, and sales of pharmaceuticals related to viral diseases [1] - Revenue composition: Chemical drugs 62.13%, Biological drugs 37.44%, Technical services 0.32%, CMO/CDMO 0.09%, Others 0.01% [1] Shareholder Insights - Zhonggeng Fund's Zhonggeng Value Leading Mixed Fund (006551) is among the top ten circulating shareholders of Kain Technology, having increased its holdings by 7,434 shares to a total of 4.5007 million shares, representing 2.63% of circulating shares [2] - The fund has realized an estimated floating profit of approximately 6.481 million CNY from this investment [2] Fund Performance - The Zhonggeng Value Leading Mixed Fund (006551) was established on December 19, 2018, with a current asset size of 2.374 billion CNY [3] - Year-to-date return is 52.97%, ranking 847 out of 8,162 in its category; the one-year return is 44.3%, ranking 1,694 out of 8,015; and since inception, the return is 238.18% [2] Fund Holdings - Kain Technology is the third-largest holding in the Zhonggeng Value Leading Mixed Fund, accounting for 5.04% of the fund's net value [4]